Who is John Adlesich and some of his health industry accomplishments on healthcare industry trends: Think outside your ZIP code. With the emergence of virtual services and virtual workforces, the talent pool is expanding and new entrants are emerging that can offer services at a lower cost and often at a higher quality than is possible for some organizations. One example is the collaboration between tele-ICU service providers and small, rural hospitals to improve their patients’ access to highly specialized critical care. Organizations also have increased flexibility to find personnel in clinical areas, such as subspecialty radiologists, and to cover nonclinical areas where it’s difficult to recruit talent, such as revenue cycle specialists, IT staff and customer service representatives.
John Adlesich on behavior therapy in 2021: PRT is derived from Applied Behavioral Analysis and uses many of the same principals. However, the therapy strategies are more child-directed than observation-directed. The treatment focuses on pivotal behaviors like communication, social skills, academic skills, and the self-monitoring of behaviors. AutismSpeaks.org indicates that PRT techniques are: Effective for eliminating or redirecting challenging behaviors and promoting socially significant behaviors Can be implemented by trained psychologists, speech therapists, special education teachers, and parents Certifiable through The Koegel Autism Center, although certification is not required Offered in both structured and unstructured formats in six short segments that target language, play, and skill acquisition Implemented for about 25 hours each week A lifestyle as much as a therapy and are designed to complement family routines.
John Adlesich on healthcare industry trends in 2021: Democratic control in the Senate will also impact healthcare. For example, Washington state Senator Patty Murray will chair the Senate Committee on Health, Education, Labor, and Pensions. She has advocated for a more robust federal response on COVID-19. And Senator Ron Wyden, Oregon, leads the Finance Committee and has pushed for drug pricing reform and drug price negotiation. These appointments and nominations point to a strong emphasis on COVID-19 recovery and vaccine distribution and coordination. For example, Fauci remains as the Director of the National Institute of Allergies and Infectious Diseases, and there’s now a COVID-19 data director (Shahpar), indicating this administration will emphasize data and reporting. Also evident in these appointments is a Biden administration focus on health equity and healthcare disparities—particularly with Nunez-Smith as the first Equity Task Force Chair for COVID-19. John Adlesich currently works as administrator at Marquis Companies. His latest healthcare industry experience includes positions as executive director at Powerback Rehabilitation Lafayette (Genesis Healthcare) between Aug 2020 – Jan 2021, administrator at Mesa Vista of Boulder between Mar 2019 – Aug 2020, chief executive officer at Sedgwick County Memorial Hospital between Jul 2018 – Feb 2019, interim chief operating officer at Toiyabe Indian Health Project between Mar 2018 – Jun 2018.
John Adlesich believes that 2021 is a crossroads year for the health industry. There will be particular momentum for programs that have bipartisan support, including payment policies that move away from fee-for-service reimbursement and toward models that drive lower-cost and higher-quality outcomes. The overall movement to value will get a shot in the arm from two principal forces in 2021: 1) the Biden Administration’s commitment to build on the ACA’s legacy by doubling down on alternative payment models and mandatory payment changes and 2) the pandemic. When it comes to policy, the new Administration will not need convincing that value-based care improves quality and reduces costs. Ample research shows that since the move to value began, overall health spending as a percent of GDP has slowed, cutting more than $600 billion out of the budget trajectory that was predicted in 2010. Because these programs are net savers, expanding their reach will be an important and immediate objective that could be used to offset some of the COVID-19 relief spending. To that end, we are likely to see Biden’s HHS make fee-for-service less attractive and push at least some mandatory alternative payment models. In addition, the Administration is also likely to move beyond endless testing of models, making proven programs permanent, creating added incentives to enable scale, and leading the way for private payers to follow suit with value-based programs of their own.